Instrument Inactif

Communiqués Precision Therapeutics Inc Nasdaq

Actions

US74033P1003

Recherche biotechnologique et médicale

Communiqués

07/07	Axe Compute Inc. Joins Russell Microcap® Index, Reflecting Its Growth as a Publicly Traded AI Infrastructure Platform	AQ
16/06	Axe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute	AQ
27/05	Axe Compute Receives $43M Payment for Landmark Contract	AQ
15/05	Axe Compute Inc. Reports First Quarter 2026 Financial Results and Provides Business Update	AQ
11/05	Axe Compute to Host Q1 2026 Financial Results Conference Call	AQ
04/05	Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6	AQ
28/04	Axe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global Conference	AQ
22/04	Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment	AQ
20/04	Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve	AQ
06/04	Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team	AQ
01/04	Axe Compute Reports $12 Million in Executed Agreements Providing $835 Thousand in Estimated Monthly Income Entering Q2 2026	AQ
31/03	Axe Compute Inc. Reports Full-Year 2025 Financial Results	AQ
27/03	Axe Compute to Host Annual Report Conference Call	AQ
17/03	Axe Compute Appoints Two Technology and Telecom Luminaries to Board of Directors as Company Accelerates AI Infrastructure Strategy	AQ
24/02	Axe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus	AQ
09/02	Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute	AQ
15/01	DNA Holdings Publishes In-Depth Research on Axe Compute (NASDAQ: AGPU), Highlighting the Rise of Revenue-Backed AI Compute Infrastructure	AQ
12/01	Axe Compute (NASDAQ: AGPU) Named Sponsor of the Sequire Investor Summit Puerto Rico 2026	AQ
02/12	Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement	AQ
14/11	Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy	AQ
14/10/25	Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy	AQ
08/10/25	Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy	AQ
29/09/25	Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens	AQ
25/09/25	Predictive Oncology Announces 1-for-15 Reverse Stock Split	AQ
04/09/25	Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients	AQ